IDT Biologika
End-to-End Contract Development and Manufacturing of Vaccines and Biologics
About IDT Biologika

Contract Development and Manufacturing of Vaccines and Biologics

IDT Biologika specializes in the contract development and manufacturing of vaccines, gene therapy medicinal products, sterile liquids and lyophilized biologics. We help biopharmaceutical companies with the challenging and complex process of translating vaccines and other biopharmaceuticals from the research lab through clinical development to large-scale commercial manufacturing, fill/finish, packaging and quality control. IDT Biologika provides fully integrated services for GMP compliant end-to-end services in BSL2 facilites meeting FDA and EMA standards (ANVISA ready).

We strive for strong and enduring partnerships with innovative biotech and world‘s leading biopharma companies. Our almost 100-year tradition of manufacturing vaccines and biopharmaceuticals motivates and obligates us to advance our clients’ products to prevent and treat diseases that impact the health of people worldwide.

IDT Biologika inaugurates new multifunctional production facility for vaccines at BioPharmaPark area

Friday, 5. July 2019

New building for vaccine production enables even more flexible reaction to customer demands more info

Ceva completes acquisition

Wednesday, 3. July 2019

Ceva completes acquisition of IDT veterinary business assets, moving closer to its 2020 objective of 50:50 bio-pharma split more info

IDT Biologika to concentrate on human vaccines and pharmaceuticals

Wednesday, 5. June 2019

Divestment of animal health business unit enables focus on global growth market more info

Ceva Santé Animale and IDT Biologika GmbH

Friday, 17. May 2019

Ceva Santé Animale and IDT Biologika GmbH announce agreement for Ceva to acquire the IDT animal health business, expanding its global vaccine portfolio and boosting swine innovation more info

CMO Leadership Awards 2019

Tuesday, 26. March 2019

IDT Biologika Receives Six 2019 CMO Leadership Awards more info

Twitter
@IDT Biologika

Tuesday, 16. July 2019

RT @IMG_ST: Last Friday a multifunctional production facility for human virus production was inaugurated at the #Biopharmapark in #SaxonyAn… more info

Thursday, 6. June 2019

RT @iitoLifeScience: IDT Biologika to Divest Animal Health Business Unit to Focus on Production of Human Vaccines & Medicines https://t.co/… more info

Friday, 17. May 2019

RT @CevaSanteAnimal: [Press Release] 📣 Ceva is proud to announce provisional agreement to acquire the animal health business of biopharmac… more info

Ceva completes acquisition of IDT veterinary business assets, moving closer to its 2020 objective of 50:50 bio-pharma split more info

Divestment of animal health business unit enables focus on global growth market more info

Ceva Santé Animale and IDT Biologika GmbH more info

Contact & Address

IDT as employer — Jobs for the future more info